\-\ Texto\\:\\ \ \(0\)\
\-\ unremarkable\ \(371\)\
\-\ treatment\\ \\(pleural\\ plaques\\)\\:\\ none\\.\\ \\ \ \(0\)\
\-\ follow\\-up\\:\\ continued\\ follow\\-up\\ and\\ surveillance\\ to\\ screen\\ for\\ malignant\\ mesothelioma\\.\ \(0\)\
\-\ ct\\ is\\ certainly\\ indicated\\ when\\:\\ \\ thick\\ \\(\\>1\\ cm\\)\\,\\ lobulated\\ contour\\,\\ diffuse\\ pleural\\ thickening\\,\\ associated\\ pleural\\ effusion\\,\\ or\\ evidence\\ of\\ adjacent\\ chest\\ wall\\/mediastinal\\ extension\\ are\\ all\\ suspicious\\ for\\ malignant\\ mesothelioma\\.\\ \\ malignant\\ mesotheliomas\\ have\\ calcifications\\ in\\ 20\\%\\ and\\,\\ unlike\\ benign\\ pleural\\ disease\\,\\ are\\ not\\ asbestos\\ dose\\ related\\.\ \(0\)\
\-\ cxr\\ \\(pa\\/lat\\)\\:\\ serpiginous\\,\\ geographic\\ calcified\\ densities\\ are\\ scattered\\ over\\ both\\ hemithoraces\\ consistent\\ with\\ pleural\\ plaques\\.\ \(0\)\
\-\ asbestos\\-related\\ pleural\\ disease\\-\\-\\-pleural\\ plaques\ \(0\)\
\-\ given\\ the\\ appearance\\:\\ multiple\\ and\\ bilateral\\ \\(and\\ given\\ history\\ of\\ asbestos\\ exposure\\)\\,\\ a\\ differential\\ is\\ limited\\ to\\ asbestos\\-related\\ pleural\\ disease\\.\ \(0\)\
\-\ other\\ differential\\ causes\\ for\\ pleural\\ calcification\\/thickening\\ could\\ be\\ related\\ to\\ tb\\ \\(prior\\ exudative\\ effusion\\)\\,\\ hemothorax\\ \\(any\\ cause\\)\\.\ \(0\)\
\-\ 73\\ y\\/o\\ male\\ with\\ history\\ of\\ asbestos\\ exposure\\.\\ \\ otherwise\\ asymptomatic\\.\ \(0\)\
\-\ pleural\\ plaques\\ can\\ be\\ followed\\ radiographically\\,\\ however\\,\\ ct\\ is\\ much\\ more\\ sensitive\\ in\\ defining\\ and\\ characterizing\\ these\\ plaques\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pleural\\:\\ 0\\.5230990155091019\ \(0\)\
\-\ asbestos\\:\\ 0\\.40179429588687354\ \(0\)\
\-\ plaques\\:\\ 0\\.3505365108809398\ \(0\)\
\-\ related\\:\\ 0\\.2112286999366112\ \(0\)\
\-\ mesothelioma\\:\\ 0\\.15395377218025114\ \(0\)\
\-\ malignant\\:\\ 0\\.14860003604966268\ \(0\)\
\-\ exposure\\:\\ 0\\.13207720763937308\ \(0\)\
\-\ mesotheliomas\\:\\ 0\\.1111260416522823\ \(0\)\
\-\ hemithoraces\\:\\ 0\\.1111260416522823\ \(0\)\
\-\ characterizing\\:\\ 0\\.10618686538863872\ \(0\)\
\-\ effusion\\:\\ 0\\.10320019681679525\ \(0\)\
\-\ exudative\\:\\ 0\\.09774328779596492\ \(0\)\
\-\ given\\:\\ 0\\.09560102194319953\ \(0\)\
\-\ thickening\\:\\ 0\\.09454732193752406\ \(0\)\
\-\ defining\\:\\ 0\\.09423888646693471\ \(0\)\
\-\ differential\\:\\ 0\\.09029954774413221\ \(0\)\
\-\ disease\\:\\ 0\\.08750546811241006\ \(0\)\
\-\ certainly\\:\\ 0\\.08436053393964753\ \(0\)\
\-\ serpiginous\\:\\ 0\\.0837019136771413\ \(0\)\
\-\ geographic\\:\\ 0\\.0830770840258178\ \(0\)\
\-\ are\\:\\ 0\\.079102323857476\ \(0\)\
\-\ unlike\\:\\ 0\\.0773517312815871\ \(0\)\
\-\ hemothorax\\:\\ 0\\.0773517312815871\ \(0\)\
\-\ surveillance\\:\\ 0\\.07591695634697374\ \(0\)\
\-\ and\\:\\ 0\\.07179396522187938\ \(0\)\
\-\ screen\\:\\ 0\\.07167405573137056\ \(0\)\
\-\ 73\\:\\ 0\\.07143751417247221\ \(0\)\
\-\ densities\\:\\ 0\\.06949297835347623\ \(0\)\
\-\ radiographically\\:\\ 0\\.06929490069619246\ \(0\)\
\-\ sensitive\\:\\ 0\\.0683501244812461\ \(0\)\
\-\ thick\\:\\ 0\\.06603860381968654\ \(0\)\
\-\ dose\\:\\ 0\\.06489126155111959\ \(0\)\
\-\ lobulated\\:\\ 0\\.06409653364335059\ \(0\)\
\-\ for\\:\\ 0\\.06318361225240483\ \(0\)\
\-\ contour\\:\\ 0\\.06253420249065633\ \(0\)\
\-\ suspicious\\:\\ 0\\.0620911897596928\ \(0\)\
\-\ tb\\:\\ 0\\.06187558222815011\ \(0\)\
\-\ scattered\\:\\ 0\\.060464576096239495\ \(0\)\
\-\ much\\:\\ 0\\.06018236638937797\ \(0\)\
\-\ indicated\\:\\ 0\\.0571520134960492\ \(0\)\
\-\ is\\:\\ 0\\.05708907827657442\ \(0\)\
\-\ continued\\:\\ 0\\.05693640596450652\ \(0\)\
\-\ be\\:\\ 0\\.056376805363240315\ \(0\)\
\-\ calcified\\:\\ 0\\.05597781550306167\ \(0\)\
\-\ cxr\\:\\ 0\\.05558901098247294\ \(0\)\
\-\ limited\\:\\ 0\\.0554621191317408\ \(0\)\
\-\ history\\:\\ 0\\.05309668728852573\ \(0\)\
\-\ ct\\:\\ 0\\.05290927855641111\ \(0\)\
\-\ causes\\:\\ 0\\.052506381738187044\ \(0\)\
\-\ to\\:\\ 0\\.05211540389486184\ \(0\)\
\-\ calcifications\\:\\ 0\\.0507137797870332\ \(0\)\
\-\ could\\:\\ 0\\.05054399993041977\ \(0\)\
\-\ otherwise\\:\\ 0\\.04953334534988756\ \(0\)\
\-\ extension\\:\\ 0\\.04918910401987314\ \(0\)\
\-\ benign\\:\\ 0\\.04773339505790411\ \(0\)\
\-\ cause\\:\\ 0\\.047338284502393684\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.04730592988172547\ \(0\)\
\-\ followed\\:\\ 0\\.04692423262269268\ \(0\)\
\-\ unremarkable\\:\\ 0\\.046584548806679484\ \(0\)\
\-\ adjacent\\:\\ 0\\.04504197221701768\ \(0\)\
\-\ any\\:\\ 0\\.04490854801873577\ \(0\)\
\-\ 20\\:\\ 0\\.04482918938288367\ \(0\)\
\-\ diffuse\\:\\ 0\\.043577420910891874\ \(0\)\
\-\ when\\:\\ 0\\.04197462251899337\ \(0\)\
\-\ appearance\\:\\ 0\\.04189147197415491\ \(0\)\
\-\ all\\:\\ 0\\.041364402747368925\ \(0\)\
\-\ however\\:\\ 0\\.04112862427347853\ \(0\)\
\-\ of\\:\\ 0\\.0407953360110935\ \(0\)\
\-\ cm\\:\\ 0\\.039907603746874895\ \(0\)\
\-\ evidence\\:\\ 0\\.039441351648309655\ \(0\)\
\-\ these\\:\\ 0\\.03923972209296969\ \(0\)\
\-\ prior\\:\\ 0\\.03887851885747668\ \(0\)\
\-\ both\\:\\ 0\\.03874978310165333\ \(0\)\
\-\ over\\:\\ 0\\.03863824464724829\ \(0\)\
\-\ more\\:\\ 0\\.03815620762314693\ \(0\)\
\-\ none\\:\\ 0\\.0379746165706858\ \(0\)\
\-\ consistent\\:\\ 0\\.037677853842653174\ \(0\)\
\-\ bilateral\\:\\ 0\\.037345281646234324\ \(0\)\
\-\ chest\\:\\ 0\\.036679156295991285\ \(0\)\
\-\ associated\\:\\ 0\\.03662525573229581\ \(0\)\
\-\ can\\:\\ 0\\.03646497042606196\ \(0\)\
\-\ other\\:\\ 0\\.03608610480236476\ \(0\)\
\-\ have\\:\\ 0\\.03471294322305001\ \(0\)\
\-\ in\\:\\ 0\\.034572594656550694\ \(0\)\
\-\ multiple\\:\\ 0\\.033987971430949206\ \(0\)\
\-\ treatment\\:\\ 0\\.0331007030214653\ \(0\)\
\-\ male\\:\\ 0\\.030938619896629067\ \(0\)\
\-\ not\\:\\ 0\\.027432111222637227\ \(0\)\
\-\ with\\:\\ 0\\.027213140809759426\ \(0\)\
\-\ or\\:\\ 0\\.024173551307537157\ \(0\)\
\-\ the\\:\\ 0\\.013865324224594924\ \(0\)\
